This is the authors' abstract. We don't add key points for this paper.
Incidence of HBS and its association with morbidity and mortality remains unclear in contemporary clinical practice. It is more common to encounter HBS in chronic dialysis patients with secondary hyperparathyroidism than those with primary hyperparathyroidism that undergo parathyroidectomies. Use of bisphosphonates to prevent HBS should be explored in future studies.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Jain et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: